Contract Win

GenIP Plc, a technology business providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, is pleased to announce its expansion into the Republic of Chile through an engagement for 30 analytical assessment orders from a leading research institution.

This order increases the total value of Invention Evaluator orders received by GenIP since its IPO in October 2024 to over $850,000[1].

Melissa Cruz, CEO of GenIP, commented:

"I am delighted to announce another new international contract with a leading research university, marking GenIP's first entry into the Chilean market. The institution has purchased 30 Invention Evaluator assessments, to support technology commercialisation decisions across its research portfolio. This milestone strengthens GenIP's growing footprint in Latin America and underscores global demand for its GenAI-enabled services.

"GenIP's global expansion is underpinned by a healthy balance sheet that allows the Company to capitalise on opportunities as they arise. As outlined in our audited results, the reported Operating Loss of $888,545 included $358,924 of share-based payments relating to the IPO that are not expected to recur. Customers typically pay in advance for Invention Evaluator report orders, providing the Company with operating cash flow and future revenue visibility, with revenue recognised upon completion and delivery of the report to the client. These factors help maintain the Company's strong financial position."

Company Strategy